ScoreCardiology

Contrast-induced nephropathy risk after PCI (Mehran)

Adds eight clinical and procedural factors to estimate the risk of contrast-induced nephropathy after percutaneous coronary intervention.

Updated 30 October 2026

When to use it

Patients undergoing PCI, to anticipate renal risk and intensify prevention (hydration, minimal contrast, creatinine check at 48–72 h).

What it needs

  • Peri-procedural hypotensionYes or no
  • Intra-aortic balloon pumpYes or no
  • Congestive heart failureYes or no
  • Age > 75 yearsYes or no
  • AnaemiaYes or no
  • DiabetesYes or no
  • Contrast volumeUnits: ml
  • Baseline kidney functionOptions: eGFR ≥ 60 mL/min/1.73 m² (or creatinine ≤ 1.5 mg/dL) · eGFR 40–59 · eGFR 20–39 · eGFR < 20 · Creatinine > 1.5 mg/dL (eGFR unavailable)

The points for each answer and the automatic total are in the app.

How to interpret it

Mehran score
ResultInterpretation
≤ 5Low risk (≤ 5): nephropathy ≈ 7.5 %
6–10Moderate risk (6–10): nephropathy ≈ 14 %
11–15High risk (11–15): nephropathy ≈ 26 %
≥ 16Very high risk (≥ 16): nephropathy ≈ 57 %

Practical tip

Nephropathy was defined as a creatinine rise ≥ 25 % or ≥ 0.5 mg/dL at 48 h; dialysis risk also rises with the score.

2 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top